Fei Dy1, Janine Amirault2, Paul D Mitchell3, Rachel Rosen4. 1. Division of Respiratory Diseases, Boston Children's Hospital, Boston, MA. 2. Aerodigestive Center, Division of Gastroenterology and Nutrition, Boston Children's Hospital, Boston, MA. 3. Clinical Research Center, Children's Hospital Boston, Boston, MA. 4. Aerodigestive Center, Division of Gastroenterology and Nutrition, Boston Children's Hospital, Boston, MA. Electronic address: Rachel.Rosen@childrens.harvard.edu.
Abstract
OBJECTIVES: To determine the sensitivity of salivary pepsin compared with multichannel intraluminal impedance with pH testing (pH-MII), endoscopy, and gastroesophageal reflux disease (GERD) questionnaires. STUDY DESIGN: We prospectively recruited 50 children from Boston Children's Hospital who were undergoing pH-MII to evaluate for GERD. The patients completed 24-hour pH-MII testing, completed symptom and quality of life questionnaires, and provided a saliva specimen that was analyzed using the PepTest lateral flow test. A subset of patients also underwent bronchoscopy and esophagogastroduodenoscopy. Receiver operating characteristic curve analyses were performed to determine the sensitivity of salivary pepsin compared with each reference standard. RESULTS: Twenty-one of the 50 patients (42%) were salivary pepsin-positive, with a median salivary pepsin concentration of 10 ng/mL (IQR, 10-55 ng/mL). There was no significant difference in the distributions of acid, nonacid, total reflux episodes, full column reflux, or any other reflux variable in patients who were pepsin-positive compared with those who were pepsin-negative (P > .50). There was no significant correlation between the number of reflux episodes and pepsin concentration (P > .10). There was no positive relationship between salivary pepsin positivity, any extraesophageal symptoms or quality of life scores, or inflammation on bronchoscopy or esophagogastroduodenoscopy (P > .30). CONCLUSION: Salivary pepsin measurement has a low sensitivity for predicting pathological gastroesophageal reflux in children.
OBJECTIVES: To determine the sensitivity of salivary pepsin compared with multichannel intraluminal impedance with pH testing (pH-MII), endoscopy, and gastroesophageal reflux disease (GERD) questionnaires. STUDY DESIGN: We prospectively recruited 50 children from Boston Children's Hospital who were undergoing pH-MII to evaluate for GERD. The patients completed 24-hour pH-MII testing, completed symptom and quality of life questionnaires, and provided a saliva specimen that was analyzed using the PepTest lateral flow test. A subset of patients also underwent bronchoscopy and esophagogastroduodenoscopy. Receiver operating characteristic curve analyses were performed to determine the sensitivity of salivary pepsin compared with each reference standard. RESULTS: Twenty-one of the 50 patients (42%) were salivary pepsin-positive, with a median salivary pepsin concentration of 10 ng/mL (IQR, 10-55 ng/mL). There was no significant difference in the distributions of acid, nonacid, total reflux episodes, full column reflux, or any other reflux variable in patients who were pepsin-positive compared with those who were pepsin-negative (P > .50). There was no significant correlation between the number of reflux episodes and pepsin concentration (P > .10). There was no positive relationship between salivary pepsin positivity, any extraesophageal symptoms or quality of life scores, or inflammation on bronchoscopy or esophagogastroduodenoscopy (P > .30). CONCLUSION: Salivary pepsin measurement has a low sensitivity for predicting pathological gastroesophageal reflux in children.
Authors: Elif Saritas Yuksel; Shih-Kuang S Hong; Vicki Strugala; James C Slaughter; Marion Goutte; C Gaelyn Garrett; Peter W Dettmar; Michael F Vaezi Journal: Laryngoscope Date: 2012-03-23 Impact factor: 3.325
Authors: Stephen Farrell; Cyril McMaster; David Gibson; Michael D Shields; William A McCallion Journal: J Pediatr Surg Date: 2006-02 Impact factor: 2.545
Authors: Lindsey Gumer; Rachel Rosen; Benjamin D Gold; Eric H Chiou; Melanie Greifer; Sherri Cohen; Joel A Friedlander Journal: J Pediatr Gastroenterol Nutr Date: 2019-05 Impact factor: 2.839
Authors: Philip O Katz; Kerry B Dunbar; Felice H Schnoll-Sussman; Katarina B Greer; Rena Yadlapati; Stuart Jon Spechler Journal: Am J Gastroenterol Date: 2022-01-01 Impact factor: 10.864
Authors: Bryan P Hurley; Rebecca H Jugo; Ryan F Snow; Tina L Samuels; Lael M Yonker; Hongmei Mou; Nikki Johnston; Rachel Rosen Journal: Sci Rep Date: 2019-09-24 Impact factor: 4.379
Authors: Yadhavan Upendran; Steven T Leach; Harveen Singh; James McBride; Paul S Thomas; Yvonne Belessis; Usha Krishnan Journal: Front Pediatr Date: 2020-03-19 Impact factor: 3.418